FindMyRecallSubscribe
Class II: temporary or reversible health riskCompleted

Medisca Budesonide Recall

Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder,…

Medisca Inc. · Irving, TX

Risk level
Class II
Reported by FDA
Jul 10, 2024
Recall ID
D-0570-2024
Check your lot numberHow we source this data

Summary

Medisca recalled Budesonide starting Jun 26, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0570-2024 on Jul 10, 2024. Reason: CGMP Deviations and Presence of Particulate Matter: Glass. Status: Completed.

Why it was recalled

CGMP Deviations and Presence of Particulate Matter: Glass

Product description

Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.

Lot numbers, UPCs & expiration codes

Lot #s: 202323/G, 202323/H, Exp. 07/31/2026

Where it was sold

Nationwide in the USA and Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0570-2024
Classification
Class II
Status
Completed
Recall initiated
Jun 26, 2024
FDA report date
Jul 10, 2024
Quantity
113 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Medisca Inc.

Original FDA data

Every field from FDA enforcement report D-0570-2024, exactly as published.

Show all FDA fields
City
Irving
State
TX
Status
Completed
Country
United States
Event ID
94868
Address
6641 N Belt Line Rd Ste 130
Code information
Lot #s: 202323/G, 202323/H, Exp. 07/31/2026
Postal code
75063-6001
Report date
Jul 10, 2024
Product type
Drugs
Recall number
D-0570-2024
Classification
Class II
Recalling firm
Medisca Inc.
Product quantity
113 bottles
Reason for recall
CGMP Deviations and Presence of Particulate Matter: Glass
Voluntary / mandated
Voluntary: Firm initiated
Product description
Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.
Distribution pattern
Nationwide in the USA and Canada
Recall initiation date
Jun 26, 2024
Initial firm notification
Letter
Center classification date
Jun 28, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0570-2024, published Jul 10, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls